STAT

JUNE 28, 2023

But the trauma that patients experience as they deal with the disease can pose a lifelong risk to their mental health, according to a recent analysis published in JAMA Pediatrics. The meta-analysis of 52 clinical studies measured the prevalence and severity of psychological disorders in over 20,000 young cancer survivors.

280

280

Outsourcing Pharma

MARCH 5, 2024

Clerkenwell Health, a company that delivers clinical trials for the treatment of complex mental health volunteers for trials into the use of psychoactive medications for treating PTSD, is in search of 40 ex-military volunteers.

111

111

STAT

MAY 25, 2023

Biobank , a major genomics and health endeavor with data from half a million participants, to build a new research facility and to enhance collaboration with industry and academia. The initiative includes a $190 million infusion into the U.K. has fallen behind other countries in running such studies.

Packaging 244

Packaging Pharmaceutical Manufacturing 244

Outsourcing Pharma

MARCH 27, 2024

In an exciting collaboration, modern mental health company, Clerkenwell Health, and Beckley Psytech, a clinical-stage biotechnology company, have launched a phase 2a study aimed at investigating a potential breakthrough treatment for alcohol use disorder (AUD).

94

94

Digital Pharmacist

MARCH 19, 2024

Their focus on holistic health and lifestyle-based solutions have contributed to an emphasis on mental health and to recent upticks in organic and wellness trends. Approach to Holistic Health and Wellness Gen Zers favor getting and staying healthy over traditional healthcare visits.

104

104

STAT

SEPTEMBER 9, 2022

Specifically, the panel determined that the National Institute for Health and Care Excellence did not thoroughly convey its views on how uncertainties in the evidence that are “inherent to clinical trials in mental health were taken into account in its decision making.”

Drug Pricing 244

Drug Pricing 244

Pharmacy Times

MAY 9, 2024

A clinical pharmacist discusses his work in the mental health space while stressing the importance of advocating for and checking in with one another’s emotional well-being.

49

49

pharmaphorum

OCTOBER 11, 2022

An explosion of digital mental health tools being offered for sale has presented regulators with a problem – how should they be classified and assessed for safety or efficacy? Digital mental health tools are already being deployed by the NHS, but so far in a fairly haphazard manner, with few being rolled out in a coordinated way.

122

122

pharmaphorum

JULY 26, 2022

Newly diagnosed cancer patients across the UK will get free access to digital mental health therapies, thanks to a new partnership between Macmillan Cancer Support and Big Health. The post Macmillan alliance will provide digital health apps to cancer patients appeared first on. Photo by Yuris Alhumaydy on Unsplash.

134

134

pharmaphorum

AUGUST 26, 2021

A merger between two digital mental health companies – Headspace and Ginger – will create a $3 billion giant in a category that has been growing at breakneck speed as a result of the COVID-19 pandemic. ” The post Digital mental health firms Headspace and Ginger in $3bn merger appeared first on.

122

122

Pharmaceutical Technology

AUGUST 12, 2022

In June this year, it was announced that the US Food and Drug Administration (FDA) had granted UK-based OxfordVR a breakthrough device designation for its gameChangeVR treatment to deliver immersive cognitive behaviour therapy (CBT) to people suffering from schizophrenia and other mental illnesses. million people in the UK and 2.7

141

141

ALiEM - Pharm Pearls

MARCH 5, 2024

7] Toxicity from salicin mirrors toxicity from aspirin (salicylism) in its clinical presentation. With severe toxicity, patients can have altered mental status, seizures, hyperthermia, and pulmonary edema. European Journal of Clinical Pharmacology. Clinical Toxicology. European Journal of Clinical Pharmacology.

Clinical Pharmacology 283

Clinical Pharmacology Adverse Reactions Compounding 283

Pharmacy Times

MARCH 11, 2024

If clinical trials continue to show that psychedelics offer safe and long-lasting results, then psychedelic-assisted therapy could flourish as a treatment in the mental health space.

52

52

European Pharmaceutical Review

JUNE 28, 2023

The clinical trial will combine dosages of a new psilocin-based drug with specialist therapy. The novel psilocin prodrug MSP-1014, the drug being used in the clinical trial is anticipated to exert similar efficacy to psilocybin in improving symptoms of depression.

Dosage 79

Dosage Drug Development 79

pharmaphorum

DECEMBER 14, 2022

Two virtual reality startups operating in the health category – BehaVR and OxfordVR – have agreed to pool their efforts on the development of digital therapeutics (DTx) for mental illnesses via a merger. It is thought to be one of the largest collaborations involving digital health and pharma companies in the DTx category.

105

105

pharmaphorum

JULY 12, 2022

But innovative new products are only part of the equation, because even the most efficacious drugs will only work as part of a holistic programme of care that includes mental health support. Yet we know that poor mental health is associated with poorer quality of life, poorer diabetes management, and increased healthcare costs.

Diabetes 111

Diabetes Hospitals 111

pharmaphorum

MAY 9, 2022

Mental health issues among teens and young adults have risen dramatically over the past decade. In primary care, there are guidelines to screening for behavioural health concerns like depression annually. Clinical use. Providers we talk to are identifying teens who need help, and the numbers are staggering.

135

135

pharmaphorum

OCTOBER 14, 2021

UK-based Big Health has passed a digital health milestone after Scotland became the first country to make anxiety and insomnia digital therapeutics available on a national basis. Digital technologies have massive potential to help people manage and support their mental health in a way that feels right for them.

People Management 103

People Management 103

Pharmaceutical Business Review

AUGUST 6, 2023

The FDA granted the approval of ZURZUVAE based on the NEST clinical development programme, which included the ROBIN and SKYLARK studies in adult women with PPD. Sage Therapeutics CEO Barry Greene said: “Maternal mental health has been sidelined for far too long, but today’s approval of ZURZUVAE helps to change that. “In

Controlled Substances 98

Controlled Substances 98

pharmaphorum

OCTOBER 22, 2021

In the latest Health Innovators video chat, pharmaphorum’s founder, Dr Paul Tunnah, chats with the founder and CEO of digital mental health pioneer Healios. This has led Healios to become the digital leader in the delivery of specialist mental health and neurodiverse clinical services for children and young people.

Communication 111

Communication 111

pharmaphorum

JANUARY 25, 2023

Digital therapeutics company Woebot Health has announced enrolment of the first patient in a pivotal clinical trial to evaluate the safety and efficacy of WB001, an investigational therapeutic for postpartum depression (PPD), granted Breakthrough Device designation by the US Food and Drug Administration (FDA) in 2021.

Dosage 105

Dosage 105

Pharmacy Times

OCTOBER 18, 2023

In the clinical setting, psychedelic medicine has promise as a safe and efficacious treatment for PTSD, TBIs, and other mental health issues.

59

59

pharmaphorum

MARCH 25, 2022

In January, PLOS Digital Health published a study which claimed that there’s “sparse” data to support the efficacy of most mental health apps. There are approximately 20,000 mental health apps and the overwhelming majority are considered “wellness” products. Consistent Standards Matter.

115

115

pharmaphorum

FEBRUARY 1, 2021

Now, drugmaker Almirall and digital health firm Happify are working on a tool to support mental health in these patients. This partnership will allow us to provide patients with psoriasis a solution based on a clinically validated positive psychology platform,” said Francesca Domenech Wuttke, Almirall’s chief digital officer.

124

124

pharmaphorum

SEPTEMBER 23, 2022

On Tuesday, Curebase announced a three-year clinical trial partnership with Meru Health, the study looking at the effectiveness of the latter’s 12-week treatment program, developed to reduce depression in primary care patients. The first is the proof-of-concept phase. It is estimated the first phase will conclude next Spring.

59

59

Putting Patients First Blog

JUNE 13, 2023

Escontrías, DrPH, MPH, Senior Vice President of Equity, Research and Programs The LGBTQ+ community faces unique health care needs, and access to mental health treatment without stigma is among the most pressing. Historically, the LGBTQ+ community has encountered many challenges in the pursuit of equality, including health.

Immunity 98

Immunity Immunization 98

Pharmacy Times

JUNE 14, 2023

Pharmacogenomics is gaining support in mental health and polypharmacy, where the data make a strong case for improvements in clinical and economic outcomes.

58

58

pharmaphorum

JANUARY 14, 2022

Japanese pharma group Otsuka has led a $10 million first-round financing of GrayMatters Health, an Israeli company developing a digital health approach to the management of mental illness. ” The cash injection will go towards completing ongoing clinical trials of the technology and securing regulatory approvals for PTSD.

Medical Schools 130

Medical Schools Hospitals 130

pharmaphorum

MARCH 2, 2022

There is a growing pipeline of psychedelic therapies and an expanding body of science to suggest that they may be able to provide an alternative to existing mental health treatments. But today this is rapidly changing as a greater number of companies and research institutes explore potential uses for mental health disorders.

Compounding 105

Compounding Drug Development 105

Putting Patients First Blog

JANUARY 11, 2024

AKF strives to help patients get diagnosed early so they can work closely with their health care team to manage their condition. link] Mayo Clinic. New NHC Project Looking at Chronic Kidney Disease Disparities January 11, 2024 By: Lillian Q. In the U.S., Centers for Disease Control and Prevention. Chronic kidney disease.

Mayo Clinic 111

Mayo Clinic Documentation 111

pharmaphorum

NOVEMBER 25, 2021

The company’s artificial intelligence-powered software uses cognitive behavioural therapy techniques to help patients suffering from a range of mental health issues, including depression and anxiety. At the same time, there are fewer than four mental health workers per 100,000 people in half the worlds’ countries, it added.

72

72

pharmaphorum

DECEMBER 20, 2022

The novel mobile application combines multiple clinically validated therapeutic interventions for use alone and in combination with pharmaceutical therapy to help people with schizophrenia achieve positive clinical outcomes. Roughly half of all patients exhibit co-occurring mental and/or behavioural health disorders.

52

52

Pharmaceutical Technology

MAY 1, 2023

Teva Pharmaceuticals and MedinCell have received approval from the US Food and Drug Administration (FDA) for Uzedy (risperidone) extended-release injectable suspension to treat adult patients with schizophrenia, a chronic, progressive, and severely debilitating mental health disorder.

75

75

European Pharmaceutical Review

DECEMBER 13, 2022

North American psychedelic drug developers Mindset, PharmAla, Mydecine and Psyence have signed with clinical research organisation (CRO) Clerkenwell Health to trial therapies for mental health conditions, in London, UK, to benefit from the country’s swift drug regulatory process.

Compounding 102

Compounding Drug Development 102

pharmaphorum

JANUARY 26, 2021

From telehealth to digital trials, customer engagement to healthcare data, Healthware Group outlines the key trends that are expected to shake up digital health this year. Mental health worsens – digital tools continue to fill the gap. Clinical trials get more and more digitalised.

Health and Personal Care Stores 141

Health and Personal Care Stores Medication Guidelines Communication 141

European Pharmaceutical Review

OCTOBER 30, 2023

A large-scale study led by researchers at the University of Cincinnati and New York’s largest health care provider, Northwell Health, suggests that metformin can help prevent or reduce weight gain in youth taking second-generation antipsychotics (SGAs) to treat bipolar disorder.

Diabetes 101

Diabetes 101

pharmaphorum

SEPTEMBER 7, 2021

A study has shown that people with anxiety or depression who used a digital therapeutic (DTx) for insomnia alongside psychological therapy, had better improvement in their mental health than those receiving therapy on its own. The post Study backs benefit of insomnia DTx Sleepio on mental health appeared first on.

64

64